SkyCell teams up with Validaide to boost pharma lane risk assessments
SkyCell’s supply chain software SkyMind will integrate with Validaide’s lane risk assessment and ground handling data.
SkyCell has partnered with Validaide, a leading lane risk assessment platform, to enhance decision-making and lane risk assessments for pharmaceutical companies.
The partnership aims to help pharmaceutical companies make better supply chain decisions by enabling data-driven routing, streamlining lane risk assessments, and accelerating lane approvals for critical shipments, according to an official release from SkyCell.
“SkyCell’s vision for pharma has always been zero loss and zero CO₂ emissions for the pharma supply chain. Technology is crucial for decision-makers to reduce costs, risks, and CO₂ emissions in pharma supply chains. Collaboration among stakeholders and technology providers is equally important. Our partnership with Validaide is a significant step forward, empowering pharmaceutical companies to take greater control of their supply chains,” says Richard Ettl, Co-Founder and CEO, SkyCell.
“The partnership will see SkyMind SkyCell‘s supply chain software platform integrate with Validaide’s lane risk assessment and ground handling data, allowing pharma companies to make better decisions based on risk, cost, and carbon emissions. SkyMind’s CO₂e software DECARBONIZE is based on the Massachusetts Institute of Technology (MIT) latest research and methodology. The DECARBONIZE software allows the comparison of one-way versus reusable packaging options, allowing companies to minimise their environmental impact while making informed decisions. With this collaboration, Validaide’s platform will be enhanced to make lane risk assessments and CO₂e comparisons with different packaging at the same time.”
“Our longstanding relationship with SkyCell has been marked by shared goals. This next step in our journey together will allow us to combine our qualitative operational data with SkyMind’s quantitative data — creating a comprehensive solution for the pharma industry. Together, we look forward to helping our customers make better, more informed supply chain decisions,” says Eelco De Jong, Co-Founder and Managing Director, Validaide.
